Beam Therapeutics (BEAM) Earnings Date, Estimates & Call Transcripts $17.48 +0.48 (+2.79%) As of 10:25 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Beam Therapeutics Earnings Summary Upcoming Earnings DateMay. 6Before Market OpensEstimatedConsensus EPS (Feb. 25) -$1.25 Actual EPS (Feb. 25) -$1.09 Beat By $0.16 Actual Revenue (Feb. 25) $30.00MBeam Therapeutics posted Q4 2024 earnings on February 25, 2025, reporting an EPS of -$1.09, which beat analysts' consensus estimates of -$1.25 by $0.16. Quarterly revenue fell 90.5% year-over-year to $30 million, above the consensus estimate of $16.47 million. With a trailing EPS of -$4.58, Beam Therapeutics' earnings are expected to grow next year, from ($4.57) to ($4.27) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)BEAM Upcoming EarningsBeam Therapeutics' Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled on Wednesday, May 7, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Beam Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Beam Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBEAM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BEAM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Beam Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20254-$1.20-$0.90-$1.05Q2 20254-$1.23-$0.90-$1.03Q3 20254-$1.22-$0.90-$1.02Q4 20254-$1.24-$0.86-$1.03FY 202516-$4.89-$3.56-$4.13Q1 20261-$0.83-$0.83-$0.83Q2 20261-$0.83-$0.83-$0.83Q3 20261-$0.83-$0.83-$0.83Q4 20261-$0.81-$0.81-$0.81FY 20264($3.30)($3.30)($3.30) Remove Ads Beam Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)--------2/25/2025Q4 2024-$1.25-$1.09+$0.16-$1.09$16.47M$30.00M11/5/2024Q3 2024-$1.16-$1.17 -$0.01-$1.17$14.52M$14.30M8/6/2024Q2 2024-$1.13-$1.11+$0.02-$1.11$14.18M$11.80M5/7/2024Q1 2024-$1.42-$1.21+$0.21-$1.21$17.09M$7.40M2/27/2024Q4 2023-$0.69$1.73+$2.42$1.73$34.16M$316.20M11/8/2023Q3 2023-$1.33-$1.22+$0.11-$1.22$17.09M$17.20M8/8/2023Q2 2023-$1.42-$1.08+$0.34-$1.08$17.32M$20.12M5/10/2023Q1 2023-$1.36-$1.33+$0.03-$1.33$14.41M$24.21M Beam Therapeutics Earnings - Frequently Asked Questions When is Beam Therapeutics's earnings date? Beam Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on BEAM's earnings history. Did Beam Therapeutics beat their earnings estimates last quarter? In the previous quarter, Beam Therapeutics (NASDAQ:BEAM) reported ($1.09) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.25) by $0.16. Learn more on analysts' earnings estimate vs. BEAM's actual earnings. How much revenue does Beam Therapeutics generate each year? Beam Therapeutics (NASDAQ:BEAM) has a recorded annual revenue of $63.52 million. How much profit does Beam Therapeutics generate each year? Beam Therapeutics (NASDAQ:BEAM) has a recorded net income of -$132.53 million. BEAM has generated -$4.58 earnings per share over the last four quarters. What is Beam Therapeutics's EPS forecast for next year? Beam Therapeutics's earnings are expected to grow from ($4.57) per share to ($4.27) per share in the next year. More Earnings Resources from MarketBeat Related Companies TGTX Earnings BBIO Earnings RVMD Earnings LEGN Earnings BPMC Earnings SRPT Earnings AXSM Earnings KRYS Earnings NUVL Earnings GRFS Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:BEAM) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beam Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beam Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BEAM Stock Free BEAM Stock Alerts